Battery Ventures, a global, technology-focused investment firm, announced the completion of its take-private of Enzo Biochem (“Enzo”), a life-science research reagents company. Enzo offers over 200,000 research reagents, including labeling and detection kits, antibodies, assays, and proteins for academic, pharmaceutical, and biotech research. Enzo’s products are cited in more than 175,000 published studies across genomic, protein, cellular, and tissue analysis. With its decades of expertise, Enzo has earned the trust of scientists worldwide for its deep catalog of products, commitment to quality and strong industry reputation.
Read the full article: Battery Ventures Completes Take-Private of Enzo Biochem //
Source: https://www.businesswire.com/news/home/20250828987506/en/Battery-Ventures-Completes-Take-Private-of-Enzo-Biochem